Filtered By:
Infectious Disease: Hepatitis
This page shows you your search results in order of date. This is page number 6.
Order by Relevance | Date
Total 2175 results found since Jan 2013.
Immunotherapy with Autoimmune Complication in Renal Cancer
CONCLUSION: Immunotherapy has very good results in advance malignancies. It has unique side effects of auto immune phenomenon. Therapy can be re-challenged if its complications of autoimmune adverse events are diagnosed and treated promptly. References Nagra NK, Siddique A, Singhvi G, et al. S2684 pembrolizumab induced hepatitis: a severe complication effectively treated with steroids. Am J Gastroenterol 2020;115:S1405-S1406. Choueiri TK, Tomczak P, Park SH, et al. Adjuvant pembrolizumab after nephrectomy in renal-cell carcinoma. N Engl J Med 2021;385:683-694.PMID:37116021
Source: Journal of the Association of Physicians of India - April 28, 2023 Category: General Medicine Authors: Sahuji Payal Sunil Santosh Kumar Shaista Hussaini Srinivas Kandula Source Type: research
Safety Profile of Eltrombopag in Different Age Groups: An Analysis of Real-World Pharmacovigilance and Randomized Clinical Trials
This study aimed to explore the clinical features of adverse drug events (ADEs) associated with eltrombopag in different age groups using ICSRs from the World Health Organization database VigiBase and the US Food and Drug Administration Adverse Event Reporting System database from 2008 to 2022 in combination with a meta-analysis of data from randomized clinical trials in the literature from inception to July 28, 2022. We conducted disproportionality analyses by grouping patients into the following age groups: 0-17 (0-23 months，2-11 years, 12-17 years), 18-64, and ≥65 years. The ADEs about hepatobiliary disorders, throm...
Source: Clinical Pharmacology and Therapeutics - April 23, 2023 Category: Drugs & Pharmacology Authors: Han Qu Jiaqi Wu Cui Ma Xijier Qiaolongbatu Xianmin Song Tingting Feng Zhenghua Wu Yuefen Lou Guorong Fan Source Type: research
